A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy

Detalles Bibliográficos
Autores principales: Maishman, Tom, Stanton, Louise, Davies, Andy, Barrans, Sharon, Worrillow, Lisa, Mamot, Christoph, Care, Matt, Immins, Tikki, Hamid, Debbie, McMillan, Andrew, Fields, Paul, Jack, Andrew, Johnson, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980503/
http://dx.doi.org/10.1186/1745-6215-14-S1-O77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980503/
http://dx.doi.org/10.1186/1745-6215-14-S1-O77

Ejemplares similares